Fri, Jul
68 New Articles

Dentons Advises RIB on Financing Farmak’s Entry in Spain

Dentons Advises RIB on Financing Farmak’s Entry in Spain

Deals and Cases
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Dentons has advised Regionala Investiciju Banka on its financing of Farmak. Cuatrecasas reportedly advised Farmak.

Regionala Investiciju Banka is the eighth largest bank in Latvia, according to assets on December 31, 2023. 

Farmak is a Ukrainian pharmaceutical company.

According to Dentons, “the transaction marks RIB’s entrance into the Spanish market. The financing is a part of RIB’s West Bridge project, a loan program, which aims to help Ukrainian businesses obtain financing for development in Europe. The loan will be used to finance the launch of a new pharmaceutical plant in Barcelona, Spain.”

“I am proud of our cooperation with Farmak and this particular project,” commented RIB representative Yuriy Voievoda. “Opening a new manufacturing facility in Europe is not an easy task for a Ukrainian business, but starting a pharmaceutical plant from scratch is many times more difficult. It was really a challenge, involving comprehensive collateral examination of large production during the construction process, financial analysis in various countries, and a new jurisdiction for Regionala Investiciju Banka – Spain.”

In 2023, Dentons advised Farmak on a series of acquisitions from a portfolio company of private equity house Novator (as reported by CEE Legal Matters on June 19, 2023).

The Dentons team included Kyiv-based Partner Natalia Selyakova and Madrid-based Partner Jabier Badiola, Senior Associate Ignacio Fernandez, and Associate Adelaida Torres.

Our Latest Issue